AOL Money & Finance

Cramer on BloggingStocks: The health care bargain

More

TheStreet.com's Jim Cramer says health care has never been this cheap relative to the market in its history.

Health care's not done rallying. As President Obama prepared himself for claiming a great political victory, we are all recognizing that the single-payer, socialized medicine covering cradle-to-grave, 100% paid for by the rich, the fear that left all things health care in the P/E dustbin, is dead. That's not going to happen.

That leaves us with the biggest bargains the market has to offer.

Health care has never been this lowly valued relative to the market in its history. Remember, 98% of the time it trades at a meaningful premium. I think that many believe some of these moves (like the Celgene (NASDAQ: CELG) (Cramer's Take) move) is because of gigantic new drug finds. In fact, I think they just got too cheap and the only thing really meaningful about the Celgene rally came because one of its Revlimid studies was stopped for good results, actually a predictable event given how well the drug works on many different kinds of cancers.

Same with Merck (NYSE: MRK) (Cramer's Take) and Pfizer (NYSE: PFE) (Cramer's Take). There was nothing really exciting about these two other than that they will be taking costs out because of mergers. Bristol Myers (NYSE: BMY) (Cramer's Take) jumped because it woke up from it slumber to buy growth, something that Johnson & Johnson's (NYSE: JNJ) (Cramer's Take) been doing all year, which is why that stock is back to $60.

This group's going to keep doing this, going to keep making these under-the-radar moves that will, in the end -- when Obama says, "Wow, we have saved the American people trillions of dollars" -- make your portfolio the only real winner in this Washington-based fiasco.

I think the diagnostics (Inverness Medical (NYSE: IMA) (Cramer's Take) is my fave), the drugs (Bristol Myers on newfound growth and Abbott (NYSE: ABT) (Cramer's Take) because it is cheap), WellPoint (NYSE: WLP) (Cramer's Take) as an almost totally non-Medicare Advantage player, Medco (NYSE: MHS) (Cramer's Take) and Express Scripts (NYSE: ESRX) (Cramer's Take), all seem poised to go higher.

I would only worry about home health care and oxygen plays -- they always seem to get hammered by the government and this time I don't think it will be any different.

Random musings: Bizarre article about me in the New York Post this weekend. I am not sure that the fact that I am a bit cuckoo and threw some computers and chairs in my youth is all that newsworthy, as anyone who watches "Mad Money" or reads "Confessions of a Street Addict," in which it is a constant theme, will attest to.

My old friend Todd Harrison, who worked with me briefly in 2000 -- just long enough to get a book out of it -- seems to think that I was ousted after a bad year. In fact, I was up 36% that year -- I am actually good at this stuff -- while the market was down, and I had more people wanting to give me money than ever. I just wanted to quit on top and I gave away the firm to my non-equity partner, Jeff Berkowitz, not to Todd. Hard to oust the guy who owns 100% and runs the place.

Todd's description of me, at least according to the article, reads far too much like the description I gave of myself in "Confessions" except mine's more vivid with a lot more anger. No wonder I quit.

Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. At the time of publication, Cramer was long Bristol-Myers, Inverness Medical and Abbott.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 26, 2009: 06:21 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines